Prof Christopher Wood

Executive Chairman

Serial entrepreneur who has founded and managed a number of successful biotechnology companies, including Bioenvision Inc (NASDAQ: BIV), and NuCana Biomed (NASDAQ: NCNA).

Ian Abercrombie

Chief Executive Officer

25 years’ experience in both clinical development and commercial settings, including senior positions at Johnson & Johnson, Bioenvision, Genzyme, Caris Life Sciences and NuCana.

Dr Fiona Dempsey

Director of Scientific Operations

Over 20 years' experience in cell biology, bioanalysis and bioprocesses. Has coordinated multiple UK and global drug development studies in compliance with GLP and GCP regulations.

James Ingham

Operations Director

Cambridge University alumnus with over 15 years’ experience in business operations, communications and PR/marketing, including 7 years within the Life Sciences sector in Scotland.

Dr Henry Hays

Project Manager

Significant expertise in antibody development, having previously held a Senior Protein Scientist role developing, characterising and scaling-up antibody drug conjugate (ADC) processes.

Joseph Milne

Clinical Project Lead

Over 15 years’ experience in clinical project management, toxicology and preclinical study management, including 7 years as Senior Clinical Project Manager for a multinational CRO.

Scott Crichton

Scientific Affairs Manager

MSc in Medical Biotechnology from Edinburgh Napier University and BSc in Cell and Molecular Biology from Western New Mexico University.

Jen McDowall

Office Manager

Over 15 years’ experience in a variety of office management, project support, logistics, customer service and front-of-house roles, internationally.

Delia Herrington

Finance Manager

Over 20 years’ experience in finance across various industries, including healthcare, energy, tourism and biotechnology.